PLoS ONE · 2015 · 71 citations · 33 references
Life SciencesNeurobiologyNeuroscienceAutism Spectrum DisordersBehavioral NeuroscienceBiological PsychologyDevelopmental Behavioral NeuroscienceDevelopmental Social NeuroscienceNeurodevelopmental DisordersPediatric NeuropsychologySocial PsychophysiologySocial Skills DeficitsSocial Behavior RegulationSocial Cognition ImpairmentSocial Functioning AssessmentSocial Functioning ImpairmentSocial ResponsivenessVasopressin BiologyVasopressin Physiology
Brain arginine vasopressin (AVP) critically regulates normative social behavior in mammals, and experimental disruption of the AVP signaling pathway produces social impairments in rodent models. We therefore hypothesized that AVP signaling deficits may contribute to social impairments in children with autism spectrum disorder (ASD). Since blood measures (which are far easier to obtain than brain measures) of AVP are most meaningful if they are related to brain AVP activity, Study 1 tested the relationship between AVP concentrations in concomitantly collected blood and CSF samples from children and adults (N = 28) undergoing clinical procedures. Study 2 tested whether blood AVP concentrations: 1) differed between children with ASD (N = 57), their ASD discordant siblings (N = 47), and neurotypical controls (N = 55); and 2) predicted social functioning (using the NEPSY-II Theory of Mind and Affect Recognition tasks and the Social Responsiveness Scale) in this large, well-characterized child cohort. Blood AVP concentrations significantly and positively predicted CSF AVP concentrations (F1,26 = 7.17, r = 0.46, p = 0.0127) in Study 1. In Study 2, blood AVP concentrations did not differ between groups or by sex, but significantly and positively predicted Theory of Mind performance, specifically in children with ASD, but not in non-ASD children (F1,144 = 5.83, p = 0.017). Blood AVP concentrations can be used: 1) as a surrogate for brain AVP activity in humans; and 2) as a robust biomarker of theory of mind ability in children with ASD. These findings also suggest that AVP biology may be a promising therapeutic target by which to improve social cognition in individuals with ASD.
33
Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 51.7K citations · Full text
Joan Kaufman, Boris Birmaher, David A. Brent et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1997 · 10.2K citations · Full text
Catherine Lord, Michael Rutter, Ann Le Couteur · Journal of Autism and Developmental Disorders · 1994 · 9.1K citations
Education, Psychiatry, Psychology +13
Catherine Lord, Susan Risi, Linda Lambrecht et al. · Journal of Autism and Developmental Disorders · 2000 · 7.6K citations
Jon Baio, Lisa D. Wiggins, Deborah Christensen et al. · MMWR Surveillance Summaries · 2018 · 5.5K citations · Full text